Get started Log in

PRTCY — Puretech Health Share News

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Market Cap
$423.23m
Enterprise Value
$146.11m
Revenue
$4.66m

Prtc Launches Celea To Advance Ph3: Ready IPF Drug
12/08/2025 12:00
Holding(s) in Company
05/08/2025 17:30
PRTC’s Seaport Begins Phase 2b Study in MDD
17/07/2025 12:05
Brief: Puretech's CEO Bharatt Chowrira Steps Down
16/07/2025 07:17
PureTech Announces Leadership Transition
16/07/2025 07:00
Brief: PureTech Says Sharon Barber-Lui Appointed Interim Board Chair
08/07/2025 18:21
Directorate Change
08/07/2025 17:45
PDMR Notification RSU Vesting
04/07/2025 17:30
PDMR Notification RSU Vesting
04/07/2025 17:30
PDMR Notification
04/07/2025 17:30
Brief: Puretech Founded Entity Vor Bio Announces Exclusive Global License Agreement With Remegen For Late-Stage Autoimmune Asset
26/06/2025 07:46
PRTC'S Vor Announces RemeGen License & $175M PIPE
26/06/2025 07:00
PureTech Health PLC Citigroup Inc - Holding(s) in Company
29/05/2025 17:30
PRTC to Present at Jefferies Healthcare Conference
22/05/2025 12:00
PRTC: IPF Data Support Lung Function Stabilization
21/05/2025 07:00
PRTC Publishes Research on Unmet IPF Patient Needs
09/05/2025 12:00
PRTC To Present Ph2b IPF Results at ATS Conference
01/05/2025 12:00
Final Results
30/04/2025 07:00
Notice of Results
23/04/2025 07:00
PureTech Health PLC Citigroup Inc - Holding(s) in Company
11/04/2025 07:00